Robert J. Shovlin, President, Clinical Services at NEOGENOMICS INC (NEO), sold 261,208 shares at $39.31 ($10.3M) on 2021-05-25, disclosed to the SEC on 2021-05-27.
Seasonal sale ($10.3M) by President, Clinical Services — this insider has traded NEO in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.31 | 130,604 | $5.1M | 50.0% |
| 2 | $39.31 | 130,604 | $5.1M | 50.0% |
| Total | $39.31 avg | 261,208 | $10.3M | 100% |
| Filing → |
| NEO | SELL | 2019-11-04 | $4.9M | — | Filing → |
| NEO | SELL | 2019-05-06 | $5.3M | — | Filing → |
| NEO | SELL | 2019-02-28 | $7.1M | — | Filing → |